Drug Trial Radar · NCT05882357
Evaluation of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis (CF) Participants 12 to Less Than 24 Months of Age
Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
67
Actual
Start
Jun 27, 2023
Primary completion
Sep 4, 2025
Study completion Sep 4, 2025
Sponsor
- Lead sponsor
- Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
- Sponsor type
- Industry
- First posted
- May 31, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Sequential
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 months, up to 24 months
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study evaluates the pharmacokinetics (PK), safety, tolerability, pharmacodynamics (PD), and efficacy of ELX/TEZ/IVA in CF participants 2 to less than (\<) 24 months of age.
Conditions
- Cystic Fibrosis
Interventions
ELX/TEZ/IVADrug
Fixed-dose combination granules for oral administration.
IVADrug
Granules for oral administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A: Observed Pre-dose Concentration (Ctrough) of ELX, TEZ, IVA, and Their Relevant Metabolites (M23-ELX, M1-TEX, M1-IVA)Time frame: At Day 15
- Part A: Safety and Tolerability as Assessed by Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)Time frame: Day 1 up to Day 43
- Part B : Safety and Tolerability as Assessed by Number of Participants With Treatment-Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)Time frame: Day 1 up to Week 28
Locations
19 sites in 7 countries. Site status is shown where the registry gives one.
Telethon Kids Institute
Nedlands, Australia
The Royal Children's Hospital
Parkville, Australia
Queensland Children's Hospital
South Brisbane, Australia
The Children's Hospital at Westmead
Westmead, Australia
The Hospital for Sick Children
Toronto, Canada
British Columbia Children's Hospital
Vancouver, Canada
Juliane Marie Center, Rigshospitalet
Copenhagen, Denmark
Charite Paediatric Pulmonology Department
Berlin, Germany
Kinderklinik III, Abt. fur Pneumologie
Essen, Germany
Medizinische Hochschule Hannover
Hanover, Germany
Erasmus Medical Center / Sophia Children's Hospital
Rotterdam, Netherlands
Inselspital - Universitaetsspital Bern
Bern, Switzerland
Kinderspital Zuerich
Zurich, Switzerland
Children and Young Adults Research Unit
Cardiff, United Kingdom
Leeds General Infirmary
Leeds, United Kingdom
Alder Hey Children's NHS Foundation Trust
Liverpool, United Kingdom
Great Ormond Street Hospital for Children
London, United Kingdom
Royal Brompton Hospital
London, United Kingdom
Southampton General Hospital
Southampton, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.